PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
ICMR’s budgetary allowance has increased by 4-fold in the past 10 years, showcasing our commitment towards Health Research
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
The National One Health Mission will help India to achieve integrated disease control and pandemic preparedness
This newly set up Centre for bio-analytical testing has already received European Regulatory Authority clearance recently
_256_384.jpg)
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The plant will drive pharmaceutical innovation in the Northeastern India
MoU to serve as the establishment of an Academic Collaboration in Ayurveda and Thai Traditional Medicine
Academic and Policy Research to get further boost, RIS will bring forth Ayush Service Sector report soon
Subscribe To Our Newsletter & Stay Updated
